Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.30 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.30 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23612453 | 0.83 | PARP1 (0.42) | HIF1AEPAS1ALOX15ALOX12CYP1A2 | |
| SCHEMBL6155424 | 0.81 | CYP4F2 (0.36) | ALOX15ALOX12CTSBTSHR | |
| SCHEMBL6157517 | 0.81 | HIF1A (0.35) | HIF1AEPAS1ALOX15ALOX12TSHR | |
| SCHEMBL6189927 | 0.79 | PTGS2 (0.38) | ALOX15ALOX12MAPTCTSB | |
| Acetic Acid SCHEMBL5482093 | 0.78 | KDM4E (0.38) | ALOX15ALOX12CYP3A4MAPTCTSB | |
| SCHEMBL6156513 | 0.78 | ALDH1A1 (0.42) | MAPTTSHRMAOB | |
| SCHEMBL30044913 | 0.78 | ALDH1A1 (0.42) | MAPTTSHRMAOB | |
| SCHEMBL13018533 | 0.77 | CTSB (0.42) | CYP3A4CTSB | |
| SCHEMBL7153474 | 0.77 | ALOX15 (0.49) | ALOX15ALOX12CYP1A2CYP3A4MAPT | |
| SCHEMBL12466081 | 0.76 | KDM1A (0.50) | MAPTCTSBPDE10AKDM1AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-114539077-A | Synthesis method of levalbuterol hydrochloride | 南京恒道医药科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114539077-A | Synthesis method of levalbuterol hydrochloride | 南京恒道医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-7205425-B2 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | CHISSO CORPORATION (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | SHIBASAKI MASAKATSU | 2007-03-15 | — | — | US | disclosed |
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2005-07-07 | — | — | US | disclosed |
| US-6632955-B1 | Optically active 1-substituted phenyl-2-nitro alcohol derivatives which are useful pharmaceutical intermediates. Enantiomotphs active 1-substituted phenyl-2-nitro alcohol derivatives. From these nitro alcohol such as albutramin and | CHISSO CORPORATION (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-0947498-A1 | OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATES, AND PROCESS FOR PREPARING THE SAME | CHISSO CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | HIF1A 1996/4885EPAS1 534/4885ALOX15 838/4885 |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | HIF1A 1996/4885EPAS1 534/4885ALOX15 838/4885 |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, SARM1 | HIF1A 1928/4885EPAS1 487/4885ALOX15 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.